Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
ANTM or AET: Which is a Better Pick in Booming HMO Industry?
by Zacks Equity Research
On a comparative analysis, we try and find out which stock - Anthem (ANTM) or Aetna (AET) - is better positioned in terms of fundamentals.
Higher Optum Revenues to Drive UnitedHealth (UNH) Q4 Earnings
by Zacks Equity Research
Increased contribution across Optum's segments should support UnitedHealth's (UNH) earnings in Q4.
5 HMO Stocks to Continue Rewarding Investors
by Sejuti Banerjea
Here are five Buy-rated HMO stocks that should be in your portfolio.
UnitedHealth's Q4 Earnings to Benefit From Higher Enrollment
by Zacks Equity Research
Higher membership across UnitedHealth's (UNH) government business, partially offset by a decline in enrollment in Commercial and Global operations will drive growth.
Robust Revenues to Drive UnitedHealth's (UNH) Q4 Earnings
by Zacks Equity Research
UnitedHealth's (UNH) Q4 earnings are likely to gain traction from improved enrollment, higher revenues from health service and benefit business plus a strong capital management.
The Zacks Analyst Blog Highlights: Anthem, Humana, Centene, Molina Healthcare and Joint
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Anthem, Humana, Centene, Molina Healthcare and Joint
3 Outperformers from Health Insurance in 2017
by Zacks Equity Research
The health insurance industry has witnessed regulatory uncertainties around Affordable Care Act, public exchange losses and inorganic growth in 2017.
Anthem Buys HealthSun to Expand Medicare Business in Florida
by Zacks Equity Research
Anthem's (ANTM) buyout of HealthSun reflects its long-term strategy to grow in the Medicare Advantage business.
Can CVS Health Recover From the Shocks of 2016 & 17?
by Zacks Equity Research
CVS Health (CVS) looks for ways to return to growth.
Humana's Medicare Business Impresses, Public Exchange Hurts
by Zacks Equity Research
Although Humana (HUM) continues to grow on the back of Medicare and Medicaid expansions, threats from its exchange business weigh on both revenues and margins.
Anthem (ANTM) Grows on Membership, Rising Expenses Hurt
by Zacks Equity Research
Anthem's (ANTM) revenues gain from solid membership base and rising net investment income. However, public exchange loss and rising expenses continue to bother.
Anthem's (ANTM) Notes Receive Rating Action From A.M Best
by Zacks Equity Research
Anthem (ANTM) receives favorable ratings from the rating agencies on the back of operational excellence and financial flexibility
Ensign Group (ENSG) Q3 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) earnings missed estimates in Q3 but grew year over year due to higher revenues.
Humana (HUM) Beats Q3 Earnings Estimates, Revenues Miss
by Zacks Equity Research
Humana's (HUM) strong third-quarter earnings were driven by significantly low share count.
Tenet Healthcare's (THC) Q3 Loss Narrower Than Expected
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter results were affected by lower revenues and higher expenses.
Can Retail Segment Further Drive Humana's (HUM) Q3 Earnings?
by Zacks Equity Research
Humana's (HUM) third-quarter results are likely to be driven by strong performance of its Retail segment.
Molina Healthcare (MOH) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter earnings were driven by solid revenue growth.
Community Health (CYH) Incurs Wider-Than-Expected Loss in Q3
by Zacks Equity Research
Community Health's (CYH) third-quarter loss was wider than expected due to huge cat loss.
Teladoc (TDOC) Q3 Loss Wider Than Expected, Revenues Top
by Zacks Equity Research
Teladoc's (TDOC) third-quarter revenues grew year over year on higher visits.
Aetna (AET) Tops Q3 Earnings Estimates, Raises 2017 Guidance
by Zacks Equity Research
Aetna's (AET) solid third-quarter results were largely driven by continued strong performance in the company's Health Care segment.
LifePoint Health's (LPNT) Q3 Earnings and Revenues Miss
by Zacks Equity Research
LifePoint Health's (LPNT) third-quarter earnings missed estimates and declined year over year owing to lower revenues.
Company News For Oct 26, 2017
by Zacks Equity Research
Companies in the news are: NOC,AKAM,V,ANTM
Anthem (ANTM) in Focus: Stock Moves 5.4% Higher
by Zacks Equity Research
Anthem, Inc. (ANTM) was a big mover last session, as the company saw its shares more than 5% on the day amid huge volumes.
Universal Health (UHS) Q3 Earnings, Revenues Lag Estimates
by Zacks Equity Research
Universal Health's (UHS) third-quarter earnings were driven by solid revenue growth.
Anthem's (ANTM) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) strong third-quarter results were driven by solid enrollment growth.